Aripiprazole-induced parkinsonism and its association with dopamine and serotonin receptor polymorphisms

J Clin Psychopharmacol. 2008 Jun;28(3):352-3. doi: 10.1097/JCP.0b013e318172757f.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Alleles
  • Antipsychotic Agents / therapeutic use
  • Antipsychotic Agents / toxicity*
  • Aripiprazole
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Humans
  • Male
  • Parkinsonian Disorders / chemically induced*
  • Parkinsonian Disorders / genetics*
  • Piperazines / therapeutic use
  • Piperazines / toxicity*
  • Polymorphism, Genetic / genetics*
  • Psychotic Disorders / drug therapy*
  • Psychotic Disorders / genetics*
  • Quinolones / therapeutic use
  • Quinolones / toxicity*
  • Receptor, Serotonin, 5-HT2A / genetics*
  • Receptors, Dopamine D2 / genetics*
  • Risk Factors

Substances

  • Antipsychotic Agents
  • Piperazines
  • Quinolones
  • Receptor, Serotonin, 5-HT2A
  • Receptors, Dopamine D2
  • Aripiprazole